Legal and responsibility

Accessibility statement

NovaPharm targets WCAG 2.2 Level AA and corrects verified barriers rather than treating automated checks as complete proof.

Effective
30 July 2026
Last reviewed
30 July 2026
Version
2.0
Document owner
NovaPharm Board
Review schedule
Annual or after material change
Approval status
Company policy; external legal review where noted
01

Commitment and implementation

The application uses semantic landmarks, skip links, visible focus, labelled controls, error summaries, responsive layouts, reduced-motion support, intrinsic image dimensions and accessible status messages.

02

Testing and current status

Automated accessibility checks, Chromium and WebKit rendering, keyboard, zoom, reflow, contrast and screen-reader sampling form the acceptance approach. NovaPharm does not claim full conformance until live and independent review gates pass.

03

Help and feedback

Use the contact route to identify the page or document and the format or assistance required. NovaPharm will assess a reasonable accessible alternative and an escalation route.

Report an accessibility issue